Zai Lab
Zai Lab Limited is a global biopharmaceutical company focused on developing innovative therapies for patients with significant unmet medical needs. Founded in 2013 and headquartered in Shanghai, China, Zai Lab operates in the biotechnology sector with a strong presence in the United States. The company is dedicated to advancing drug discovery, clinical development, and commercialization, aiming to positively impact one million patients by 2030. Zai Lab's portfolio includes several commercialized products, such as ZEJULA for ovarian cancer, OPTUNE for glioblastoma, and QINLOCK for gastrointest
Investing activity
Zai Lab is listed on AI Lounge as a venture capital investor based in Shanghai, China. The deals desk records Series A and later AI rounds and seeds over $10M, so smaller checks may not show here yet.
Deals
Frequently asked questions about Zai Lab
Where is Zai Lab based?
Zai Lab is based in Shanghai, China.
How can founders reach Zai Lab?
Founders on AI Lounge can see Zai Lab's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Zai Lab to their Investor Pipeline to track the conversation.